Benefits
Cortisol-Reducing Activity
RiaGev-FEM clinically proven to reduce cortisol levels in women — addresses cortisol-driven changes that often begin before first menopausal symptoms.
Faster Acting Than Other Cortisol-Lowering Ingredients
BLS positioning emphasizes shorter time to cortisol reduction than other ingredients in this category.
No Side Effects
Cortisol-lowering effects without typical side effects of cortisol-modulating ingredients.
Perimenopausal Applications
Specifically targets cortisol changes that occur well before first menopausal symptom — proactive perimenopausal support.
Versatile Combination Capability
Can be combined with other beneficial botanicals and bioactives for comprehensive women's health benefits.
Bioenergy Ribose + B3 Foundation
Built on BLS's RiaGev foundation (NAD+ and ATP support) with women-specific applications.
Mechanism of action
Cortisol Pathway Modulation
Specific mechanism for cortisol reduction in women — BLS proprietary research.
Bioenergy Ribose Energy Support
D-ribose component supports cellular ATP — relevant to fatigue often accompanying hormonal changes.
Niacinamide NAD+ Support
Vitamin B3 component supports NAD+ — relevant to cellular energy and aging.
Women-Specific Formulation
Tailored for women's specific hormonal/cortisol patterns vs general RiaGev.
Clinical trials
BLS clinical evaluation of RiaGev-FEM specifically in women.
Women including perimenopausal.
Cortisol reduction; women's wellness markers.
About this ingredient
RIAGEV-FEM is a NEWER WOMEN-SPECIFIC VARIANT of BIOENERGY LIFE SCIENCE's (BLS) RiaGev formulation — combining Bioenergy Ribose with vitamin B3 in formulation specifically targeting WOMEN'S CORTISOL-DRIVEN HORMONAL CHANGES. CORTISOL CONTEXT: cortisol-related changes often begin well before first menopausal symptom; rising cortisol contributes to many perimenopausal symptoms; addressing cortisol proactively supports women's wellness across hormonal transitions.
KEY DISTINCTIONS: (1) WOMEN-SPECIFIC formulation; (2) CORTISOL REDUCTION focus; (3) FASTER acting than other cortisol-lowering ingredients; (4) NO SIDE EFFECTS positioning; (5) Combinable with other botanicals; (6) BLS RiaGev foundation.
EVIDENCE-BASED USES: (1) Cortisol reduction in women; (2) Perimenopausal hormonal balance; (3) Stress management for women; (4) Women's wellness; (5) Premenopausal cortisol support.
CRITICAL CAUTIONS: (1) NEWER INGREDIENT — clinical evidence base developing; (2) CORTISOL CONTEXT — significantly elevated cortisol or stress warrants medical evaluation for: adrenal disorders, depression, sleep disorders; supplements adjunctive; (3) DOSE — per BLS specification; (4) PREGNANCY — limited specific data; AVOID concentrated supplementation; (5) RIAGEV-FEM vs RIAGEV (general) — RIAGEV-FEM women-specific; RIAGEV broader healthy aging applications; same foundation; (6) RIAGEV-FEM vs RIAGEV-M — BLS women's vs men's variants; targeted formulations; (7) RIAGEV-FEM vs ASHWAGANDHA (KSM-66, Sensoril) vs OTHER ADAPTOGENS — different mechanisms; multiple cortisol/stress options; (8) FOR COMPREHENSIVE WOMEN'S HORMONAL HEALTH — sleep, exercise, stress management, possibly therapy or medications, supplements adjunct; lifestyle foundational; (9) BRAND VERIFICATION — RiaGev-FEM is BLS trademark; specific women-targeted formulation.